CAPTRUST Financial Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,678
| Closed | -$237K | – | 2567 |
|
|
2025
Q1 | $237K | Buy |
26,678
+6,085
| +30% | +$54K | ﹤0.01% | 2087 |
|
|
2024
Q4 | $282K | Buy |
20,593
+5,519
| +37% | +$75.7K | ﹤0.01% | 1953 |
|
|
2024
Q3 | $413K | Sell |
15,074
-170
| -1% | -$4.66K | ﹤0.01% | 1687 |
|
|
2024
Q2 | $373K | Buy |
15,244
+180
| +1% | +$4.4K | ﹤0.01% | 1674 |
|
|
2024
Q1 | $321K | Sell |
15,064
-11,512
| -43% | -$245K | ﹤0.01% | 1738 |
|
|
2023
Q4 | $509K | Sell |
26,576
-207
| -0.8% | -$3.96K | ﹤0.01% | 1729 |
|
|
2023
Q3 | $430K | Buy |
+26,783
| New | +$430K | ﹤0.01% | 1741 |
|
|
2022
Q3 | – | Sell |
-5,272
| Closed | -$96K | – | 3296 |
|
|
2022
Q2 | $96K | Buy |
5,272
+189
| +4% | +$3.44K | ﹤0.01% | 2218 |
|
|
2022
Q1 | $128K | Buy |
5,083
+2,581
| +103% | +$65K | ﹤0.01% | 2081 |
|
|
2021
Q4 | $69K | Sell |
2,502
-65
| -3% | -$1.79K | ﹤0.01% | 2424 |
|
|
2021
Q3 | $83K | Buy |
2,567
+41
| +2% | +$1.33K | ﹤0.01% | 2220 |
|
|
2021
Q2 | $77K | Sell |
2,526
-177
| -7% | -$5.4K | ﹤0.01% | 2217 |
|
|
2021
Q1 | $82K | Buy |
2,703
+2,558
| +1,764% | +$77.6K | ﹤0.01% | 2098 |
|
|
2020
Q4 | $3K | Sell |
145
-462
| -76% | -$9.56K | ﹤0.01% | 3011 |
|
|
2020
Q3 | $8K | Buy |
607
+70
| +13% | +$923 | ﹤0.01% | 2372 |
|
|
2020
Q2 | $6K | Buy |
+537
| New | +$6K | ﹤0.01% | 2353 |
|
|
2019
Q4 | – | Sell |
-537
| Closed | -$15K | – | 1502 |
|
|
2019
Q3 | $15K | Buy |
+537
| New | +$15K | ﹤0.01% | 1390 |
|